D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

TRVI holding history

Trevi Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TRVI overview All 13F holders of TRVI Full Q2 2026 holdings

Shares (Q2 2026): 281,996
Value: $5.26M
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of TRVI by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	281,996	$5.26M	<0.1%	+100,652+55.5%	Added	Holders
Q1 2026	181,344	$2.16M	<0.1%	+40,032+28.3%	Added	Holders
Q4 2025	141,312	$1.77M	<0.1%	+141,312	New	Holders